Mycophenolic acid activation of p53 requires ribosomal proteins L5 and L11

Research output: Contribution to journalArticle

77 Citations (Scopus)

Abstract

Mycophenolate mofetil (MMF), a prodrug of mycophenolic acid (MPA), is widely used as an immunosuppressive agent. MPA selectively inhibits inosine monophosphate dehydrogenase (IMPDH), a rate-limiting enzyme for the de novo synthesis of guanine nucleotides, leading to depletion of the guanine nucleotide pool. Its chemotherapeutic effects have been attributed to its ability to induce cell cycle arrest and apoptosis. MPA treatment has also been shown to induce and activate p53. However, the mechanism underlying the p53 activation pathway is still unclear. Here, we show that MPA treatment results in inhibition of pre-rRNA synthesis and disruption of the nucleolus. This treatment enhances the interaction of MDM2 with L5 and L11. Interestingly, knockdown of endogenous L5 or L11 markedly impairs the induction of p53 and G1 cell cycle arrest induced by MPA. These results suggest that MPA may trigger a nucleolar stress that induces p53 activation via inhibition of MDM2 by ribosomal proteins L5 and L11.

Original languageEnglish (US)
Pages (from-to)12387-12392
Number of pages6
JournalJournal of Biological Chemistry
Volume283
Issue number18
DOIs
StatePublished - May 2 2008

Fingerprint

Mycophenolic Acid
Chemical activation
Guanine Nucleotides
Cells
G1 Phase Cell Cycle Checkpoints
Inosine Monophosphate
RNA Precursors
Prodrugs
Immunosuppressive Agents
Cell Cycle Checkpoints
ribosomal protein L5
ribosomal protein L11
Oxidoreductases
Apoptosis
Enzymes

ASJC Scopus subject areas

  • Biochemistry
  • Cell Biology
  • Molecular Biology

Cite this

Mycophenolic acid activation of p53 requires ribosomal proteins L5 and L11. / Sun, Xiao-Xin; Dai, Mushui; Lu, Hua.

In: Journal of Biological Chemistry, Vol. 283, No. 18, 02.05.2008, p. 12387-12392.

Research output: Contribution to journalArticle

@article{84c10b4c27244d76a5a0974c34ed984f,
title = "Mycophenolic acid activation of p53 requires ribosomal proteins L5 and L11",
abstract = "Mycophenolate mofetil (MMF), a prodrug of mycophenolic acid (MPA), is widely used as an immunosuppressive agent. MPA selectively inhibits inosine monophosphate dehydrogenase (IMPDH), a rate-limiting enzyme for the de novo synthesis of guanine nucleotides, leading to depletion of the guanine nucleotide pool. Its chemotherapeutic effects have been attributed to its ability to induce cell cycle arrest and apoptosis. MPA treatment has also been shown to induce and activate p53. However, the mechanism underlying the p53 activation pathway is still unclear. Here, we show that MPA treatment results in inhibition of pre-rRNA synthesis and disruption of the nucleolus. This treatment enhances the interaction of MDM2 with L5 and L11. Interestingly, knockdown of endogenous L5 or L11 markedly impairs the induction of p53 and G1 cell cycle arrest induced by MPA. These results suggest that MPA may trigger a nucleolar stress that induces p53 activation via inhibition of MDM2 by ribosomal proteins L5 and L11.",
author = "Xiao-Xin Sun and Mushui Dai and Hua Lu",
year = "2008",
month = "5",
day = "2",
doi = "10.1074/jbc.M801387200",
language = "English (US)",
volume = "283",
pages = "12387--12392",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "18",

}

TY - JOUR

T1 - Mycophenolic acid activation of p53 requires ribosomal proteins L5 and L11

AU - Sun, Xiao-Xin

AU - Dai, Mushui

AU - Lu, Hua

PY - 2008/5/2

Y1 - 2008/5/2

N2 - Mycophenolate mofetil (MMF), a prodrug of mycophenolic acid (MPA), is widely used as an immunosuppressive agent. MPA selectively inhibits inosine monophosphate dehydrogenase (IMPDH), a rate-limiting enzyme for the de novo synthesis of guanine nucleotides, leading to depletion of the guanine nucleotide pool. Its chemotherapeutic effects have been attributed to its ability to induce cell cycle arrest and apoptosis. MPA treatment has also been shown to induce and activate p53. However, the mechanism underlying the p53 activation pathway is still unclear. Here, we show that MPA treatment results in inhibition of pre-rRNA synthesis and disruption of the nucleolus. This treatment enhances the interaction of MDM2 with L5 and L11. Interestingly, knockdown of endogenous L5 or L11 markedly impairs the induction of p53 and G1 cell cycle arrest induced by MPA. These results suggest that MPA may trigger a nucleolar stress that induces p53 activation via inhibition of MDM2 by ribosomal proteins L5 and L11.

AB - Mycophenolate mofetil (MMF), a prodrug of mycophenolic acid (MPA), is widely used as an immunosuppressive agent. MPA selectively inhibits inosine monophosphate dehydrogenase (IMPDH), a rate-limiting enzyme for the de novo synthesis of guanine nucleotides, leading to depletion of the guanine nucleotide pool. Its chemotherapeutic effects have been attributed to its ability to induce cell cycle arrest and apoptosis. MPA treatment has also been shown to induce and activate p53. However, the mechanism underlying the p53 activation pathway is still unclear. Here, we show that MPA treatment results in inhibition of pre-rRNA synthesis and disruption of the nucleolus. This treatment enhances the interaction of MDM2 with L5 and L11. Interestingly, knockdown of endogenous L5 or L11 markedly impairs the induction of p53 and G1 cell cycle arrest induced by MPA. These results suggest that MPA may trigger a nucleolar stress that induces p53 activation via inhibition of MDM2 by ribosomal proteins L5 and L11.

UR - http://www.scopus.com/inward/record.url?scp=45549098246&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=45549098246&partnerID=8YFLogxK

U2 - 10.1074/jbc.M801387200

DO - 10.1074/jbc.M801387200

M3 - Article

C2 - 18305114

AN - SCOPUS:45549098246

VL - 283

SP - 12387

EP - 12392

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 18

ER -